Camurus submits its first CDP disclosure

In September, Camurus submitted its first disclosure to the Carbon Disclosure Project (CDP), marking an important step in the company’s sustainability journey.

“Our first CDP disclosure aligns with Camurus’ long-term sustainability goals and our ambition to contribute to a healthier and more sustainable society”, says Iris Rehnström, Sustainability Director at Camurus. “By reporting our data and progress through CDP, we reinforce our commitment to transparency and continuous improvement, while driving efforts to reduce our carbon footprint across the value chain in line with our environmental goals.”

Participating in CDP further strengthens Camurus’ dedication to sustainability and transparency. Through this recognized platform, the company demonstrates accountability for its climate impact, benchmarks performance against industry peers, and responds to growing expectations from investors, customers, and regulators for credible and comparable sustainability data. 

CDP is a global non-profit that operates the world’s leading environmental disclosure system. More than 23,000 companies worldwide report to CDP, sharing data on climate impact, risks, opportunities, and strategies for reducing emissions. This transparency enables stakeholders to better understand how organizations manage their environmental responsibilities.

See Camurus’ CDP report at: https://www.camurus.com/files/Sustainability/camurus-cdp-report-20250919.pdf

To learn more about CDP, see: https://www.cdp.net/en

About Camurus
Camurus is an international, science-led biopharmaceutical company committed to developing and commercializing innovative, long-acting medicines for improving the lives of patients with severe and chronic diseases. New drug products with best-in-class potential are conceived based on the company’s proprietary FluidCrystal^® technology and its extensive R&D expertise. The R&D pipeline includes products for the treatment of dependence, pain, cancer, and endocrine diseases. Camurus has operations across Europe, the US, and Australia, with headquarters in Lund, Sweden. The company’s shares are listed on Nasdaq Stockholm under the ticker CAMX. For more information, visit www.camurus.com and LinkedIn.